Status:
COMPLETED
DANish Patients With Atrial Fibrillation and Sleep Apnea Prevalence by Night Owl
Lead Sponsor:
Herlev and Gentofte Hospital
Collaborating Sponsors:
Sygekassernes Helsefond
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18-90 years
Brief Summary
A project of the feasibility of using NightOwl to detect the prevalence of obstructive sleep apnea (OSA) in patients with atrial fibrillation (AF). The long-term aim is to use the device to screen for...
Detailed Description
Patients diagnosed with any type of AF referred to anticoagulation initiation at a nurse-run ambulatory will beasked to participate. The ambulatory consists of four daily nurse-led tracks at Departmen...
Eligibility Criteria
Inclusion
- Diagnosis of AF of any type
- Age \< 90 years
- Age \>18 years
Exclusion
- Known sleep apnea
- Secondary AF (post-surgical, due to infection, thyroid-induced)
- Known or newly discovered severe ventricular ectopic beats (as defined by the NightOwl manual)
- Professional drivers
- Severe heart failure (New York Heart Association class III or IV)
- Severe chronic obstructive pulmonary disease (use of home oxygen)
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04760002
Start Date
January 25 2021
End Date
January 1 2023
Last Update
March 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev-Gentofte Hospital
Copenhagen, Denmark